↓ Skip to main content

Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response

Overview of attention for article published in Frontiers in oncology, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response
Published in
Frontiers in oncology, April 2019
DOI 10.3389/fonc.2019.00323
Pubmed ID
Authors

Noura Al-Zeheimi, Adviti Naik, Charles Saki Bakheit, Marwa Al Riyami, Adil Al Ajarrah, Suaad Al Badi, Khalid Al Baimani, Kamran Malik, Zamzam Al Habsi, Mansour S. Al Moundhri, Sirin A. Adham

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 16%
Student > Postgraduate 2 11%
Student > Doctoral Student 2 11%
Unspecified 1 5%
Librarian 1 5%
Other 2 11%
Unknown 8 42%
Readers by discipline Count As %
Medicine and Dentistry 6 32%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Unspecified 1 5%
Immunology and Microbiology 1 5%
Business, Management and Accounting 1 5%
Other 0 0%
Unknown 9 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2020.
All research outputs
#8,538,940
of 25,385,509 outputs
Outputs from Frontiers in oncology
#3,358
of 22,432 outputs
Outputs of similar age
#148,227
of 363,499 outputs
Outputs of similar age from Frontiers in oncology
#90
of 299 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,499 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 299 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.